COLL - Collegium Pharmaceutical Inc. (COLL) Q1 2024 Earnings Call Transcript
2024-05-09 19:32:08 ET
Collegium Pharmaceutical, Inc. (COLL)
Q1 2024 Results Conference Call
May 09, 2024 04:30 PM ET
Company Participants
Christopher James - Vice President of Investor Relations
Joe Ciaffoni - Chief Executive Officer
Colleen Tupper - Chief Financial Officer
Scott Dreyer - Chief Commercial Officer
Mike Heffernan - Chairman
Conference Call Participants
David Amsellem - Piper Sandler
Les Sulewski - Truist Securities
Oren Livnat - H.C. Wainwright
Presentation
Operator
Greetings. And welcome to the Collegium Pharmaceutical First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation [Operator Instructions]. Please note that this conference call is being recorded.
I will now turn the call over to Christopher James, Vice President of Investor Relations at Collegium. Thank you. You may begin....
Collegium Pharmaceutical, Inc. (COLL) Q1 2024 Earnings Call Transcript